87 research outputs found
Grupo Comunitário de Porto Alegre - Leigos para o Desenvolvimento
Comunicação apresentada no 3º Encontro Conhecimento e Cooperação, INA, Lisboa, 17 de setembro de 201
Recommended from our members
Multipotent Mesenchymal Stromal Cells and Lung Disease: Not Ready for Prime Time
Moving stem cell therapy to patients with idiopathic pulmonary fibrosis
See article, page 101
Recommended from our members
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
Recommended from our members
Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?
With the combination of ideologic beliefs and the will to survive, fraught patients and determined clinicians seek alternative therapies for treatment of terminal conditions, such as idiopathic pulmonary fibrosis. Unfortunately, the need for treatment has supported the growth of unapproved stem cell therapy over the years spanning across many countries. The reality, however, is that the science behind this therapy is lagging. While there have been promising results from phase I trials, there remain multiple reasons that "stem cells" are not ready for clinical application, starting from a gap in understanding at the bench research level, all the way to optimal clinical application in order to provide effective therapy
- …